Home » Healthcare » Asia Pacific Oral Solid Dosage Contract Manufacturing Market

Asia Pacific Oral Solid Dosage Contract Manufacturing Market by Type Segment (Tablets, Capsules, Powders, Granules, Others); by Mechanism Segment (Immediate Release, Delayed Release, Controlled Release); by End-user Segment (Large Companies, SMEs); by Therapeutic Area Segment (Cardiovascular, CNS, Gastrointestinal, Oncology, Others) – Growth, Future Prospects & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

Asia Pacific Oral Solid Dosage Contract Manufacturing Market Overview

The Asia Pacific market for oral solid dosage contract manufacturing, valued at USD 10,928.68 million in 2023, is projected to experience a compound annual growth rate (CAGR) of 7.27% from 2023 to 2032. This growth trajectory is set to culminate in a valuation of USD 21,001.62 million by 2032. This growth trajectory is primarily fueled by an escalating demand for pharmaceutical products in the region, a trend towards increased outsourcing by pharmaceutical companies, and significant investments in advanced manufacturing technologies by contract development and manufacturing organizations (CDMOs).

The major contributors to revenue in this sector are China, India, and Japan, thanks to supportive government policies, the availability of cost-effective skilled labor, enhanced healthcare infrastructure, and substantial patient population bases. The contract manufacturing services in this sector predominantly focus on solid oral dosage forms, including tablets, capsules, powders, and granules, which are witnessing robust demand across the Asia-Pacific region.

Prominent players in the Asia Pacific oral solid dosage CDMO landscape include Catalent, Lonza, Recipharm AB, Patheon Inc., and Divi’s Laboratories Ltd., among others. These companies are strategically expanding their capacities and capabilities to cater to the diverse needs of biopharmaceutical customers across the value chain. Furthermore, the burgeoning growth in biologics and highly potent active pharmaceutical ingredients (APIs) is anticipated to unveil new growth avenues for the market.

Nevertheless, the market faces certain challenges, such as intense price competition leading to narrow profit margins, stringent regulatory requirements concerning manufacturing practices, and varied data protection policies across different nations. Despite these challenges, the overarching trend of rising pharmaceutical demand coupled with the inclination towards outsourcing manufacturing processes are key factors propelling the market’s growth.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

The Asia Pacific region is emerging as a significant hub for the Oral Solid Dosage (OSD) Contract Manufacturing Market, with several factors driving its growth. Key market drivers include:

Increasing Outsourcing Volume by Pharmaceutical Companies: There’s a growing trend of pharmaceutical companies outsourcing their production needs, which is significantly driving the demand for contract manufacturing services in the region.
Regulatory Environment and Quality Standards: Particularly in China, changes in the regulatory environment are aligning with international quality standards, making it an attractive location for OSD contract manufacturing. This is complemented by a large pool of skilled workers and expanding knowledge of complex formulations, enhancing the region’s appeal for pharmaceutical companies.
Aging Population in Japan: In Japan, the aging population is influencing the market, creating a demand for patient-centric formulations. The focus on quality control and good manufacturing practices in Japan is establishing the country as a reliable center for OSD contract manufacturing.
Market Competition and Technological Advancements: The market is characterized by intense competition among leading vendors who are strategically expanding their facilities, adopting new technologies, and forming partnerships to capture a larger market share.
Product Types and Mechanisms: The market is segmented into various product types like tablets, capsules, powders, and granules, with different mechanisms such as controlled-release, delayed-release, and immediate-release. Tablets are leading the market due to their widespread use, manufacturing efficiency, and cost-effectiveness.
Diverse End-User Base: The market serves a broad range of end-users, including large-size companies, medium- and small-size companies, and others, catering to their specific needs and requirements.

Key players in the market are actively involved in mergers, acquisitions, and partnerships to strengthen their market positions. Some notable players include Catalent Inc., Lonza Group, Piramal Pharma Solutions, Aenova, Jubilant, Boehringer Ingelheim, AbbVie Contract Manufacturing, Patheon, Recipharm, and others.

These factors collectively contribute to the dynamic and growing nature of the OSD contract manufacturing market in the Asia-Pacific region, making it an increasingly important area for the pharmaceutical manufacturing industry.

Market Restraints

The Asia-Pacific oral solid dosage contract manufacturing market faces several challenges. Stringent regulatory approval requirements demand high compliance standards, adding to the complexity for contract manufacturers. The market is intensely competitive, with numerous players ranging from small to large, which may lead to price wars and thinning profit margins. Economic factors like inflation, interest rates, and exchange rates also play a crucial role in shaping demand and manufacturing processes. Additionally, the threat of substitutes, including other dosage forms and natural alternatives, can impact market share. Furthermore, a declining customer base could potentially hinder market growth. Despite these obstacles, the market is expected to grow, driven by increasing investments from contract development and manufacturing organizations (CDMOs), rising demand for services, and the region’s substantial contribution to the industry’s expansion.

Opportunities

The Asia-Pacific oral solid dosage contract manufacturing market offers several growth opportunities, including the rising demand for generic pharmaceuticals due to cost-effectiveness and the expiration of patents on branded drugs. The overall growth of the pharmaceutical industry in this region, driven by an increasing population and the prevalence of chronic diseases, is another significant factor. Technological advancements in manufacturing processes are likely to enhance efficiency and quality, giving manufacturers a competitive edge. The market also benefits from the potential expansion into emerging markets with growing healthcare needs.

Investment in research and development can lead to innovation in oral solid dosage forms, opening new market segments. Strategic partnerships and collaborations with pharmaceutical companies for novel therapeutic development can provide new business avenues. Focusing on specialized and niche markets, like high-potency active pharmaceutical ingredients (HPAPIs) or controlled-release formulations, can attract specific customer segments. Lastly, adherence to stringent regulatory standards and a focus on high-quality production can enhance the credibility and reputation of manufacturers, leading to increased business opportunities.

Interesting Facts about the Asia-Pacific Oral Solid Dosage Contract Manufacturing Market

The market is experiencing a decline in its customer base for contract manufacturers. This trend is leading to increased competition among manufacturers, who are now actively enhancing their offerings to meet the diverse expectations of sponsor companies.
Despite the challenges, the oral solid dosage market in the Asia-Pacific region is expected to continue growing at a healthy rate. This growth is accompanied by a surge in demand for development and manufacturing support services for oral solid dosages.
The region held over one-third of the global market share in 2022, highlighting its significant contribution to the oral solid dosage contract manufacturing industry.
There’s a growing market opportunity for high-potency products. This includes specialized products like fixed-dose combinations, orally disintegrating tablets, minitablets, flavored chewables, double-layered tablets, and multiple-layer tablets.
Japan is highly focused on quality control in manufacturing. The country is striving to establish itself as a reliable center for the contract production of oral solid doses, particularly due to its aging population.
China has emerged as a dominant force in the oral solid dosage contract manufacturing industry, particularly in East Asia. By 2034, China is projected to hold an 80.5% share of the market in this region, driven by its large-scale manufacturing capabilities and evolving regulatory standards.

Competitive Landscape

The competitive landscape of the Asia-Pacific Oral Solid Dosage Contract Manufacturing market is characterized by the presence of several key players, each employing various strategies to strengthen their market position. These strategies include product innovation, mergers and acquisitions, expansion into new markets, and enhancing production capabilities. Some of the notable players in the Asia-Pacific Oral Solid Dosage Contract Manufacturing market are:

Catalent, Inc.
Lonza
AbbVie Inc.
Aenova Group
Adare Pharma Solutions
Boehringer-Ingelheim International GmbH
Jubilant Pharmova Limited
Thermo Fisher Scientific
Recipharm AB
Corden Pharma International
Siegfried Holding AG
Piramal Enterprises Ltd.
Saffron Medicare Pvt. Ltd.
Aurobindo Pharma Ltd.
Reddy’s Laboratories Ltd.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Regional Analysis

The Asia Pacific region is a pivotal player in the global oral solid dosage (OSD) contract manufacturing industry, holding more than one-third of the market share as of 2022. This dominant position highlights the region’s significant contribution to the sector, driven by a combination of factors including robust manufacturing capabilities, growing pharmaceutical markets, and evolving regulatory landscapes. Particularly in East Asia, China has established itself as a leading force in the industry. By 2034, China is projected to command an impressive 80.5% share of the market in East Asia, underscoring its substantial manufacturing capacity and increasing alignment with international quality standards.

In contrast, Japan is renowned for its stringent focus on quality control, striving to position itself as a reliable hub for the contract production of oral solid doses. This commitment to quality is a key differentiator for Japan in the global market, reflecting its dedication to high manufacturing standards and innovative pharmaceutical practices. This growth is indicative of the region’s developed healthcare infrastructure and rigorous regulatory environment. On the other hand, North America emerges as the second-most lucrative area for OSD contract manufacturing, holding a considerable market share and reflecting the region’s advanced healthcare infrastructure, technological prowess, and stringent regulatory standards.

Segmentation

By Type Segment

Tablets
Capsules
Powders
Granules
Others

By Mechanism Segment

Immediate Release
Delayed Release
Controlled Release

By end-user segment

Large Companies
SMEs

By Therapeutic Area Segment

Cardiovascular
CNS
Gastrointestinal
Oncology
Others

Table of Content

Chapter No. 1 :………. Introduction.. 40

1.1. Report Description. 40

1.1.1. Purpose of the Report 40

1.1.2. USP & Key Offerings. 40

1.2. Key Benefits for Stakeholders. 40

1.3. Target Audience. 41

1.4. Report Scope 42

Chapter No. 2 :………. Executive Summary. 44

2.1. OSD Contract Manufacturing Market Snapshot. 44

2.2. Asia Pacific OSD Contract Manufacturing Market, 2018 – 2032 (USD Million) 45

Chapter No. 3 :………. Geopolitical Crisis Impact Analysis. 46

3.1. Russia-Ukraine and Israel-Palestine War Impacts. 46

3.1.1. Geopolitical Instability. 46

3.1.2. Supply chain disruptions. 46

3.1.3. Regulatory Challenges. 46

3.1.4. Economic Impact 46

3.1.5. Asia Pacific Market Dynamics. 46

Chapter No. 4 :………. OSD Contract Manufacturing Market – Industry Analysis. 47

4.1. Introduction 47

4.2. Market Drivers 48

4.2.1. Complexity of New Molecules. 48

4.2.2. Advances in Drug Delivery. 48

4.2.3. Growing Demand for Oral Solid Dosages. 48

4.2.4. Expansion of Manufacturing Units. 49

4.2.5. Patent Expiry and Increasing Demand For Generic Drugs 49

4.3. Market Restraints. 50

4.3.1. Stringent Government Regulations. 50

4.3.2. High Competition among CDMOs. 50

4.3.3. Cultural Gaps and Time Zones. 50

4.4. Market Opportunities. 51

4.4.1. Technological Advancements. 51

4.4.2. Particle Engineering. 51

4.4.3. Mergers and Collaborations with Pharma and Biotech Firms. 51

4.4.4. Flexible Business Models. 51

4.5. Porter’s Five Forces Analysis. 52

4.6. Value Chain Analysis. 54

Chapter No. 5 :………. Competitive Landscape Analysis. 55

5.1. Company Market Share Analysis – 2023. 55

5.1.1. Asia Pacific OSD Contract Manufacturing Market: Company Market Share, by Revenue, 2023. 55

5.1.2. Asia Pacific OSD Contract Manufacturing Market: Top 6 Company Market Share, by Revenue, 2023. 56

5.1.3. Asia Pacific OSD Contract Manufacturing Market: Top 3 Company Market Share, by Revenue, 2023. 57

5.1. Asia Pacific OSD Contract Manufacturing Market Company Revenue Market Share, 2023. 58

5.2. Company Assessment Metrics, 2023. 59

5.2.1. Stars 59

5.2.2. Emerging Leaders. 59

5.2.3. Pervasive Players. 59

5.2.4. Participants. 60

5.3. Strategic Developments. 60

5.3.1. Acquisitions & Mergers. 60

5.3.2. Agreements & Collaborations. 62

5.3.3. Expansion. 63

5.4. Key Players Product Matrix. 64

Chapter No. 6 :………. PESTEL & Adjacent Market Analysis. 68

6.1. PESTEL 68

6.1.1. Political Factors. 68

6.1.2. Economic Factors. 68

6.1.3. Social Factors. 68

6.1.4. Technological Factors. 68

6.1.5. Environmental Factors. 69

6.1.6. Legal Factors. 69

6.2. Adjacent Market Analysis. 70

Chapter No. 7 :………. OSD Contract Manufacturing Market – By Type Segment Analysis. 72

7.1. OSD Contract Manufacturing Market Overview, by Type Segment. 72

7.1.1. Key Types. 72

7.1.2. OSD Contract Manufacturing Market Revenue Share, By Type, 2023 & 2032. 73

7.1.3. OSD Contract Manufacturing Market Attractiveness Analysis, By Type. 74

7.1.4. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032. 75

7.1.5. OSD Contract Manufacturing Market Revenue, By Type, 2018, 2023, 2027 & 2032. 76

7.2. Tablets 77

7.3. Capsules 78

7.4. Powders 79

7.5. Granules 80

7.6. Others 81

Chapter No. 8 :………. OSD Contract Manufacturing Market – By Mechanism Segment Analysis. 82

8.1. OSD Contract Manufacturing Market Overview, by Mechanism Segment 82

8.1.1. Key Mechanism Segments. 82

8.1.2. OSD Contract Manufacturing Market Revenue Share, By Mechanism, 2023 & 2032. 83

8.1.3. OSD Contract Manufacturing Market Attractiveness Analysis, By Mechanism.. 84

8.1.4. Incremental Revenue Growth Opportunity, by Mechanism, 2024 – 2032. 85

8.1.5. OSD Contract Manufacturing Market Revenue, By Mechanism, 2018, 2023, 2027 & 2032. 86

8.2. Immediate Release. 87

8.3. Delayed Release. 88

8.4. Controlled Release. 89

Chapter No. 9 :………. OSD Contract Manufacturing Market – By End-user Segment Analysis. 90

9.1. OSD Contract Manufacturing Market Overview, by End-user Segment 90

9.1.1. Key End-user Segments. 90

9.1.2. OSD Contract Manufacturing Market Revenue Share, By End-user, 2023 & 2032. 91

9.1.3. OSD Contract Manufacturing Market Attractiveness Analysis, By End-user. 92

9.1.4. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032. 93

9.1.5. OSD Contract Manufacturing Market Revenue, By End-user, 2018, 2023, 2027 & 2032. 94

9.2. Large Companies. 95

9.3. SMEs 96

Chapter No. 10 :…….. OSD Contract Manufacturing Market – By Therapeutic Area Segment Analysis. 97

10.1. OSD Contract Manufacturing Market Overview, by Therapeutic Area Segment 97

10.1.1. Key Therapeutic Area Segments. 97

10.1.2. OSD Contract Manufacturing Market Revenue Share, By Therapeutic Area, 2023 & 2032. 98

10.1.3. OSD Contract Manufacturing Market Attractiveness Analysis, By Therapeutic Area. 99

10.1.4. Incremental Revenue Growth Opportunity, by Therapeutic Area, 2024 – 2032. 100

10.1.5. OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032. 101

10.2. Cardiovascular 102

10.3. CNS 103

10.4. Gastrointestinal 104

10.5. Oncology 105

10.6. Others 106

Chapter No. 11 :…….. OSD Contract Manufacturing Market – Asia Pacific. 107

11.1. Asia Pacific 107

11.2. Key Highlights 108

11.2.1. Asia Pacific OSD Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 109

11.2.2. Asia Pacific OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 111

11.2.3. Asia Pacific OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 112

11.2.4. Asia Pacific OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 113

11.2.5. Asia Pacific OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 114

11.2.6. China 115

11.2.6.1. China OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 115

11.2.6.2. China OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 116

11.2.6.3. China OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 117

11.2.6.4. China OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 118

11.2.7. Japan 119

11.2.7.1. Japan OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 119

11.2.7.2. Japan OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 120

11.2.7.3. Japan OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 121

11.2.7.4. Japan OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 122

11.2.8. South Korea. 123

11.2.8.1. South Korea OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 123

11.2.8.2. South Korea OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 124

11.2.8.3. South Korea OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 125

11.2.8.4. South Korea OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 126

11.2.9. India 127

11.2.9.1. India OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 127

11.2.9.2. India OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 128

11.2.9.3. India OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 129

11.2.9.4. India OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 130

11.2.10. Australia. 131

11.2.10.1. Australia OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 131

11.2.10.2. Australia OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 132

11.2.10.3. Australia OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 133

11.2.10.4. Australia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 134

11.2.11. Thailand. 135

11.2.11.1. Thailand OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 135

11.2.11.2. Thailand OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 136

11.2.11.3. Thailand OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 137

11.2.11.4. Thailand OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 138

11.2.12. Indonesia. 139

11.2.12.1. Indonesia OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 139

11.2.12.2. Indonesia OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 140

11.2.12.3. Indonesia OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 141

11.2.12.4. Indonesia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 142

11.2.13. Vietnam.. 143

11.2.13.1. Vietnam OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 143

11.2.13.2. Vietnam OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 144

11.2.13.3. Vietnam OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 145

11.2.13.4. Vietnam OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 146

11.2.14. Malaysia. 147

11.2.14.1. Malaysia OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 147

11.2.14.2. Malaysia OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 148

11.2.14.3. Malaysia OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 149

11.2.14.4. Malaysia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 150

11.2.15. Philippines. 151

11.2.15.1. Philippines OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 151

11.2.15.2. Philippines OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 152

11.2.15.3. Philippines OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 153

11.2.15.4. Philippines OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 154

11.2.16. Taiwan. 155

11.2.16.1. Taiwan OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 155

11.2.16.2. Taiwan OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 156

11.2.16.3. Taiwan OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 157

11.2.16.4. Taiwan OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 158

11.2.17. Rest of Asia Pacific. 159

11.2.17.1. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 159

11.2.17.2. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 160

11.2.17.3. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 161

11.2.17.4. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 162

Chapter No. 12 :…….. Company Profiles. 163

12.1. Catalent, Inc. 163

12.1.1. Company Overview.. 163

12.1.2. Product Portfolio. 164

12.1.3. Financial Overview.. 164

12.2. Lonza 165

12.2.1. Company Overview.. 165

12.2.2. Product Portfolio. 166

12.2.3. Financial Overview.. 166

12.3. AbbVie Inc. 167

12.3.1. Company Overview.. 167

12.3.2. Product Portfolio. 168

12.3.3. Financial Overview.. 168

12.4. Aenova Group 169

12.4.1. Company Overview.. 169

12.4.2. Product Portfolio. 170

12.4.3. Financial Overview.. 170

12.5. Adare Pharma Solutions. 171

12.5.1. Company Overview.. 171

12.5.2. Product Portfolio. 172

12.5.3. Financial Overview.. 172

12.6. Boehringer Ingelheim International GmbH.. 173

12.6.1. Company Overview.. 173

12.6.2. Product Portfolio. 174

12.6.3. Financial Overview.. 174

12.7. Jubilant Pharmova Limited. 175

12.7.1. Company Overview.. 175

12.7.2. Product Portfolio. 175

12.7.3. Financial Overview.. 176

12.8. Thermo Fisher Scientific. 177

12.8.1. Company Overview.. 177

12.8.2. Product Portfolio. 177

12.8.3. Financial Overview.. 178

12.9. Recipharm AB 179

12.9.1. Company Overview.. 179

12.9.2. Product Portfolio. 180

12.9.2.1. Financial Overview.. 180

12.10. Corden Pharma International 181

12.10.1. Company Overview.. 181

12.10.2. Product Portfolio. 182

12.10.3. Financial Overview.. 182

12.11. Siegfried Holding AG.. 183

12.11.1. Company Overview.. 183

12.11.2. Product Portfolio. 184

12.11.3. Financial Overview.. 184

12.12. Piramal Enterprises Ltd. 185

12.12.1. Company Overview.. 185

12.12.2. Product Portfolio. 186

12.12.3. Financial Overview.. 186

12.13. Saffron Medicare PVT. LTD.. 187

12.13.1. Company Overview.. 187

12.13.2. Product Portfolio. 188

12.13.3. Financial Overview.. 188

12.14. Aurobindo Pharma Ltd. 189

12.14.1. Company Overview.. 189

12.14.2. Product Portfolio. 190

12.14.3. Financial Overview.. 190

12.15. Dr. Reddy’s Laboratories Ltd. 191

12.15.1. Company Overview.. 191

12.15.2. Product Portfolio. 192

12.15.3. Financial Overview.. 192

Chapter No. 13 :…….. Research Methodology. 193

13.1. Research Methodology. 193

13.2. Phase I – Secondary Research. 194

13.3. Phase II – Data Modeling. 194

13.3.1. Company Share Analysis Model 195

13.3.2. Revenue Based Modeling. 195

13.4. Phase III – Primary Research. 196

13.5. Research Limitations. 197

13.5.1. Assumptions. 197

List of Figures

FIG NO. 1……….. Asia Pacific OSD Contract Manufacturing Market Revenue, 2018 – 2032 (USD Million) 45

FIG NO. 2……….. Porter’s Five Forces Analysis for Asia Pacific OSD Contract Manufacturing Market 52

FIG NO. 3……….. Value Chain Analysis for Asia Pacific OSD Contract Manufacturing Market 54

FIG NO. 4……….. Company Share Analysis, 2023. 55

FIG NO. 5……….. Company Share Analysis, 2023. 56

FIG NO. 6……….. Company Share Analysis, 2023. 57

FIG NO. 7……….. OSD Contract Manufacturing Market – Company Revenue Market Share, 2023. 58

FIG NO. 8……….. Company Assessment Metrics. 59

FIG NO. 9……….. OSD Contract Manufacturing Market Revenue Share, By Type, 2023 & 2032. 73

FIG NO. 10……… Market Attractiveness Analysis, By Type. 74

FIG NO. 11……… Incremental Revenue Growth Opportunity by Type, 2024 – 2032. 75

FIG NO. 12……… OSD Contract Manufacturing Market Revenue, By Type, 2018, 2023, 2027 & 2032. 76

FIG NO. 13……… Asia Pacific OSD Contract Manufacturing Market for Tablets, Revenue (USD Million) 2018 – 2032. 77

FIG NO. 14……… Asia Pacific OSD Contract Manufacturing Market for Capsules, Revenue (USD Million) 2018 – 2032. 78

FIG NO. 15……… Asia Pacific OSD Contract Manufacturing Market for Powders, Revenue (USD Million) 2018 – 2032. 79

FIG NO. 16……… Asia Pacific OSD Contract Manufacturing Market for Granules, Revenue (USD Million) 2018 – 2032. 80

FIG NO. 17……… Asia Pacific OSD Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032. 81

FIG NO. 18……… OSD Contract Manufacturing Market Revenue Share, By Mechanism, 2023 & 2032. 83

FIG NO. 19……… Market Attractiveness Analysis, By Mechanism.. 84

FIG NO. 20……… Incremental Revenue Growth Opportunity by Mechanism, 2024 – 2032. 85

FIG NO. 21……… OSD Contract Manufacturing Market Revenue, By Mechanism, 2018, 2023, 2027 & 2032. 86

FIG NO. 22……… Asia Pacific OSD Contract Manufacturing Market for Immediate Release, Revenue (USD Million) 2018 – 2032. 87

FIG NO. 23……… Asia Pacific OSD Contract Manufacturing Market for Delayed Release, Revenue (USD Million) 2018 – 2032. 88

FIG NO. 24……… Asia Pacific OSD Contract Manufacturing Market for Controlled Release, Revenue (USD Million) 2018 – 2032. 89

FIG NO. 25……… OSD Contract Manufacturing Market Revenue Share, By End-user, 2023 & 2032. 91

FIG NO. 26……… Market Attractiveness Analysis, By End-user 92

FIG NO. 27……… Incremental Revenue Growth Opportunity by End-user, 2024 – 2032. 93

FIG NO. 28……… OSD Contract Manufacturing Market Revenue, By End-user, 2018, 2023, 2027 & 2032. 94

FIG NO. 29……… Asia Pacific OSD Contract Manufacturing Market for Large Companies, Revenue (USD Million) 2018 – 2032. 95

FIG NO. 30……… Asia Pacific OSD Contract Manufacturing Market for SMEs, Revenue (USD Million) 2018 – 2032. 96

FIG NO. 31……… OSD Contract Manufacturing Market Revenue Share, By Therapeutic Area, 2023 & 2032. 98

FIG NO. 32……… Market Attractiveness Analysis, By Therapeutic Area. 99

FIG NO. 33……… Incremental Revenue Growth Opportunity by Therapeutic Area, 2024 – 2032. 100

FIG NO. 34……… OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032. 101

FIG NO. 35……… Asia Pacific OSD Contract Manufacturing Market for Cardiovascular, Revenue (USD Million) 2018 – 2032. 102

FIG NO. 36……… Asia Pacific OSD Contract Manufacturing Market for CNS, Revenue (USD Million) 2018 – 2032. 103

FIG NO. 37……… Asia Pacific OSD Contract Manufacturing Market for Gastrointestinal, Revenue (USD Million) 2018 – 2032. 104

FIG NO. 38……… Asia Pacific OSD Contract Manufacturing Market for Oncology, Revenue (USD Million) 2018 – 2032. 105

FIG NO. 39……… Asia Pacific OSD Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032. 106

FIG NO. 40……… Asia Pacific OSD Contract Manufacturing Market Revenue, 2018 – 2023 (USD Million) 107

FIG NO. 41……… Research Methodology – Detailed View.. 193

FIG NO. 42……… Research Methodology. 194

List of Tables

TABLE NO. 1. :…. Asia Pacific OSD Contract Manufacturing Market: Snapshot 28

TABLE NO. 2. :…. Drivers for the OSD Contract Manufacturing Market: Impact Analysis. 32

TABLE NO. 3. :…. Restraints for the OSD Contract Manufacturing Market: Impact Analysis. 34

TABLE NO. 4. :…. Asia Pacific OSD Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 93

TABLE NO. 5. :…. Asia Pacific OSD Contract Manufacturing Market Revenue, By Country, 2024 – 2032 (USD Million) 94

TABLE NO. 6. :…. Asia Pacific OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 95

TABLE NO. 7. :…. Asia Pacific OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 95

TABLE NO. 8. :…. Asia Pacific OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 96

TABLE NO. 9. :…. Asia Pacific OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 96

TABLE NO. 10. :.. Asia Pacific OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 97

TABLE NO. 11. :.. Asia Pacific OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 97

TABLE NO. 12. :.. Asia Pacific OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 98

TABLE NO. 13. :.. Asia Pacific OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 98

TABLE NO. 14. :.. China OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 99

TABLE NO. 15. :.. China OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 99

TABLE NO. 16. :.. China OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 100

TABLE NO. 17. :.. China OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 100

TABLE NO. 18. :.. China OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 101

TABLE NO. 19. :.. China OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 101

TABLE NO. 20. :.. China OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 102

TABLE NO. 21. :.. China OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 102

TABLE NO. 22. :.. Japan OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 103

TABLE NO. 23. :.. Japan OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 103

TABLE NO. 24. :.. Japan OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 104

TABLE NO. 25. :.. Japan OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 104

TABLE NO. 26. :.. Japan OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 105

TABLE NO. 27. :.. Japan OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 105

TABLE NO. 28. :.. Japan OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 106

TABLE NO. 29. :.. Japan OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 106

TABLE NO. 30. :.. South Korea OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 107

TABLE NO. 31. :.. South Korea OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 107

TABLE NO. 32. :.. South Korea OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 108

TABLE NO. 33. :.. South Korea OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 108

TABLE NO. 34. :.. South Korea OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 109

TABLE NO. 35. :.. South Korea OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 109

TABLE NO. 36. :.. South Korea OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 110

TABLE NO. 37. :.. South Korea OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 110

TABLE NO. 38. :.. India OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 111

TABLE NO. 39. :.. India OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 111

TABLE NO. 40. :.. India OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 112

TABLE NO. 41. :.. India OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 112

TABLE NO. 42. :.. India OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 113

TABLE NO. 43. :.. India OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 113

TABLE NO. 44. :.. India OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 114

TABLE NO. 45. :.. India OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 114

TABLE NO. 46. :.. Australia OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 115

TABLE NO. 47. :.. Australia OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 115

TABLE NO. 48. :.. Australia OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 116

TABLE NO. 49. :.. Australia OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 116

TABLE NO. 50. :.. Australia OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 117

TABLE NO. 51. :.. Australia OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 117

TABLE NO. 52. :.. Australia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 118

TABLE NO. 53. :.. Australia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 118

TABLE NO. 54. :.. Thailand OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 119

TABLE NO. 55. :.. Thailand OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 119

TABLE NO. 56. :.. Thailand OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 120

TABLE NO. 57. :.. Thailand OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 120

TABLE NO. 58. :.. Thailand OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 121

TABLE NO. 59. :.. Thailand OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 121

TABLE NO. 60. :.. Thailand OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 122

TABLE NO. 61. :.. Thailand OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 122

TABLE NO. 62. :.. Indonesia OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 123

TABLE NO. 63. :.. Indonesia OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 123

TABLE NO. 64. :.. Indonesia OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 124

TABLE NO. 65. :.. Indonesia OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 124

TABLE NO. 66. :.. Indonesia OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 125

TABLE NO. 67. :.. Indonesia OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 125

TABLE NO. 68. :.. Indonesia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 126

TABLE NO. 69. :.. Indonesia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 126

TABLE NO. 70. :.. Vietnam OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 127

TABLE NO. 71. :.. Vietnam OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 127

TABLE NO. 72. :.. Vietnam OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 128

TABLE NO. 73. :.. Vietnam OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 128

TABLE NO. 74. :.. Vietnam OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 129

TABLE NO. 75. :.. Vietnam OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 129

TABLE NO. 76. :.. Vietnam OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 130

TABLE NO. 77. :.. Vietnam OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 130

TABLE NO. 78. :.. Malaysia OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 131

TABLE NO. 79. :.. Malaysia OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 131

TABLE NO. 80. :.. Malaysia OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 132

TABLE NO. 81. :.. Malaysia OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 132

TABLE NO. 82. :.. Malaysia OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 133

TABLE NO. 83. :.. Malaysia OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 133

TABLE NO. 84. :.. Malaysia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 134

TABLE NO. 85. :.. Malaysia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 134

TABLE NO. 86. :.. Philippines OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 135

TABLE NO. 87. :.. Philippines OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 135

TABLE NO. 88. :.. Philippines OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 136

TABLE NO. 89. :.. Philippines OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 136

TABLE NO. 90. :.. Philippines OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 137

TABLE NO. 91. :.. Philippines OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 137

TABLE NO. 92. :.. Philippines OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 138

TABLE NO. 93. :.. Philippines OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 138

TABLE NO. 94. :.. Taiwan OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 139

TABLE NO. 95. :.. Taiwan OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 139

TABLE NO. 96. :.. Taiwan OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 140

TABLE NO. 97. :.. Taiwan OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 140

TABLE NO. 98. :.. Taiwan OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 141

TABLE NO. 99. :.. Taiwan OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 141

TABLE NO. 100. :. Taiwan OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 142

TABLE NO. 101. :. Taiwan OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 142

TABLE NO. 102. :. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 143

TABLE NO. 103. :. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 143

TABLE NO. 104. :. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 144

TABLE NO. 105. :. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 144

TABLE NO. 106. :. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 145

TABLE NO. 107. :. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 145

TABLE NO. 108. :. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 146

TABLE NO. 109. :. Rest of Asia Pacific OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 146

What is the projected market value of the Asia Pacific oral solid dosage contract manufacturing sector by 2032?

The Asia Pacific market for oral solid dosage contract manufacturing is projected to reach a valuation of USD 21,001.62 million by 2032. Starting from a value of USD 10,928.68 million in 2023, the market is expected to grow at a compound annual growth rate (CAGR) of 7.27% from 2023 to 2032.

What factors are driving the growth of the oral solid dosage contract manufacturing market in the Asia Pacific?

The growth of this market is primarily driven by escalating demand for pharmaceutical products in the region, increased outsourcing by pharmaceutical companies, and significant investments in advanced manufacturing technologies by contract development and manufacturing organizations (CDMOs).

Who are the major revenue contributors in the Asia Pacific oral solid dosage contract manufacturing market?

China, India, and Japan are the major contributors to revenue in the Asia Pacific oral solid dosage contract manufacturing sector. This is due to supportive government policies, the availability of cost-effective skilled labor, enhanced healthcare infrastructure, and substantial patient population bases.

What challenges does the Asia Pacific oral solid dosage contract manufacturing market face?

The market faces challenges such as intense price competition leading to narrow profit margins, stringent regulatory requirements concerning manufacturing practices, and varied data protection policies across different nations. However, the rising demand for pharmaceuticals and the trend towards outsourcing manufacturing processes are propelling the market’s growth despite these challenges.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –